How to Buy Sight Sciences Stock
Sight Sciences Inc
Sight Sciences, Inc. , an ophthalmic medical device company, engages in the development and commercialization of surgical and nonsurgical technologies for the treatment of eye diseases.
Sight Sciences stock last closed at $5.14, down 8.54% from the previous day, and has decreased 44.79% in one year. It has underperformed other stocks in the Medical Devices industry by 0.29 percentage points. Sight Sciences stock is currently +394.23% from its 52-week low of $1.04, and -54.11% from its 52-week high of $11.20.
There are currently 49.55M SGHT shares outstanding. The market value of SGHT is $254.70M. In the past 24 hours, 225,509 SGHT shares were traded.
How to Buy Sight Sciences Stock
Wondering how to invest in Sight Sciences stock? Here's how.
- Choose where to buy Sight Sciences stock: You need to decide on a stock brokerage, but don't worry - we've tested dozens of online stock brokerages and apps to help you determine where to buy Sight Sciences stock.
- Sign up for a brokerage account: Sign up for 0% commission trading with the highest-rated brokerage we've found.
- Fund your brokerage account: Pick your payment method and add your information.
- Evaluate Sight Sciences stock: The Sight Sciences ticker symbol is SGHT. Is Sight Sciences stock a good investment? Should you buy shares of SGHT? How do SGHT's underlying business fundamentals look? Do top analysts think Sight Sciences is a good buy? Why has SGHT's stock price moved recently? (Hint: Our stock analysis website can help you figure out if SGHT is a good stock to buy).
- Place your SGHT buy order: Decide if you will purchase SGHT shares at the current market price or use a limit order to buy SGHT stock at a particular price.
- Get notifications regarding your investment in SGHT: Create a watchlist to monitor your new investment in Sight Sciences shares.
Step 1: Choose where to buy Sight Sciences stock
You will need a brokerage account in order to access the NASDAQ market and buy SGHT shares.
Our preferred brokerage: eToro
We believe that eToro is the best online stock brokerage. Here's why:
- Invest in stocks with 0% commissions: Invest without commissions.
- Buy fractional shares: Even if you don't have the money to buy a full share, you can still purchase the stock.
- Access to global markets: From Tech to Energy, New York to London — you can fill your portfolio with stocks from the globe's leading exchanges.
- Social investing: eToro has a community with more than 20 million users around the world. Talk to, learn from, and copy the unique crypto portfolios of other investors.
- Security: eToro is a regulated and licensed fintech leader.
- Buy other financial assets: Such as ETFs and cryptocurrencies.
Get $10 towards your stock purchase by creating an account with eToro today.
Open eToro AccountStep 2: Sign up for a brokerage account
Now that you've chosen the right brokerage, you'll need to fill out some personal information so you are able to buy SGHT stock today.
How to Create a New Account on eToro
- Click here to get started.eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.
- Enter your personal info to create your new brokerage account.
- Submit your details by pressing the "Create Account" button. Get started with eToro today
Step 3: Fund your brokerage account
Now that you have opened your account on the stock trading app, you need to deposit funds:
Check out this video walkthrough for more details transferring funds into your investment account.
Step 4: Evaluate Sight Sciences stock
Once you have selected the best place to buy Sight Sciences stock, it's important to evaluate their stock before you invest, so you can wrap your head around the risk and upside.
Sight Sciences shares at a glance
Sight Sciences Zen Score
WallStreetZen was created to help average investors do more in-depth fundamental analysis in less time.
You can see all of the due diligence checks on SGHT's stock page.
What is the fair value of SGHT stock?
Investors use a variety of different financial metrics, analyses, models, and charts to gauge SGHT's intrinsic value.
Using relative valuations ratios:
- SGHT could be undervalued based on its P/B ratio of 2.12x, relative to Medical Devices industry P/B ratio of 3.71x
You can do additional valuation research on SGHT's stock here.
A look at SGHT Cashflows and Balance Sheet
Positive Financial Indicators:
- SGHT has cash burn of 47975000. It has sufficient cash and short-term investments to cover this for at least one year.
- SGHT has $138.13M in cash and short term investments. This is enough to cover its annual cash burn of $47.98M.
- SGHT has a low debt to equity ratio of 0.39.
- There are more short-term assets than long-term liabilities on the SGHT balance sheet.
- Total SGHT debt is lower than 5 years ago, relative to shareholder equity.
- There are more short-term assets than short-term liabilities on the SGHT balance sheet.
Negative Financial Indicators:
- SGHT profit margin has gone up by 0.52 percentage points in the past year, but the company is still unprofitable.
Is it a good time to buy SGHT stock, according to Wall Street analysts?
Out of 2 Equities analysts who give forecasts on SGHT, the consensus analyst rating on Sight Sciences is a Buy
It's important to note that analyst ratings are not stock recommendations, nor are they financial advice.
You can dive deeper into what analysts are saying on the Sight Sciences stock forecast page.
SGHT Momentum
SGHT Growth Metrics
Last year, SGHT revenue was $81.06M. During the last 5 year, SGHT's revenue has grown by 60.84% per year. This was faster than the Medical Devices industry average of 13.33%.
You can analyze SGHT's earnings and revenue performance here.
Are SGHT insiders buying or selling the stock?
Over the past 12 months, executives and large shareholders at SGHT have sold more shares than they have bought.
David Badawi, Chief Technology Officer of SGHT, was the latest SGHT insider to sell. They sold $15,887.11 worth of SGHT stock on Apr 3, 2024.
Research more about who owns SGHT shares here.
Can I rely on SGHT as an income stream?
No, Sight Sciences doesn't provide an income stream by paying out dividends.
What others are saying about SGHT
One of the major reasons eToro is our top-rated brokerage is because of its social trading community.
Click below to see what other investors have to say.
Step 5: Place your SGHT buy order
You have two main options:
- Market order: A market order is an order to buy or sell a security at the best price on the market.
Market orders are generally sufficient. - Limit order: A limit order enables you to buy or sell a security at a specific price (or better).
If you want to make sure you're buying or selling at a given price limit, use a limit order.
Press the Open Trade button and your broker will execute your order.
If you want more help with investing in stocks on eToro, watch the helpful video below:
Step 6: Get notifications regarding your investment in SGHT
Now that you own some shares in SGHT, you'll want to stay up-to-date on your stock purchase.
Put SGHT on a watchlist to get notified of the latest news about your SGHT stock.
SGHT Feed
How to Buy Stock in Sight Sciences
To summarize, here are the 6 steps for buying Sight Sciences stock:
- Choose where to buy Sight Sciences stock
- Sign up for a brokerage account
- Fund your brokerage account
- Evaluate Sight Sciences stock
- Place your SGHT buy order
- Get notifications regarding your investment in SGHT
If you need a brokerage account, eToro is our favorite option.
Get Started with eToro TodayIf you would like to get notifications regarding your new investment in Sight Sciences, hit the button below to create your watchlist.
Other "How To" Guides You Might Enjoy
FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletterInformation is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.